Skip to main content

Sign up for our newsletter

An illustration of a person doing a finger prick test

Are you interested in:

  • Hearing about the latest type 1 research breakthroughs?
  • Listening to world-class type 1 research scientists talk about their work at a local Type 1 Diabetes Discovery Day?
  • Getting invited to events where you can meet others with type 1?
  • Getting updates on our latest fundraising activities to support cure, prevention and treatment research?
  • Understanding more about how you can get involved with JDRF?

Subscribe to receive JDRF’s e-newsletters and you’ll be the first to know about all of this and more.

We promise to keep your details secure and we won’t share your information with any other organisations. If you decide you’d rather not hear from us then you can unsubscribe at any time.

Keep up to date with the latest type 1 diabetes research, news and events from JDRF.

To sign up, simply complete your details below and click subscribe.

Type 1 diabetes news

Read more
Professor Richard Oram in the Research, Innovation, Learning and Development (RILD) building at the University of Exeter.
7 March 2024

New biochip launches that detects genetic risk of type 1 diabetes

A new test by Randox, developed with JDRF-funded researchers at the University of Exeter, is the first in the world to use genetics to quickly identify who is at high risk of developing type 1 diabetes.

Read more
A graphic of a DNA double helix with a piece being removed demonstrating genetic engineering.
Cure research
21 February 2024

Primate with type 1 diabetes becomes insulin-independent after receiving gene-edited cells without immunosuppression

A transplant of stem cells grown into pancreatic islets has allowed a primate with type 1 to make its own insulin again.

Read more
A profile photo of type 1 diabetes prevention researcher, Professor Claire Meek.
Prevention research
13 February 2024

JDRF and Helmsley Trust funding leads global research push to prevent type 1 diabetes

JDRF and the Helmsley Charitable Trust have announced over £1.5 million in joint funding for five international researchers – including one UK-based researcher – to access unique data sources and unravel how type 1 diabetes develops, with the goal of preventing the condition.

Read more
A small container containing three tablets of a novel glucose-responsive oral insulin.
29 January 2024

Early research shows glucose-responsive insulin tablets are safe and effective in animals

Researchers have developed a new oral insulin that travels in an inactive state to the liver and is only activated by rising blood glucose levels.

Read more
Researcher Safiya Naina Marikar pipetting in the lab.
Research
2 January 2024

Research breakthrough shows insulin-producing cells can be regenerated

We could be one step closer to replacing the need for regular insulin injections in people living with type 1 diabetes, thanks to JDRF-funded research in Australia published this week in the Nature journal.

Read more
The Rt. Hon Theresa May MP giving a reading at St Paul's Cathedral
Events
20 December 2023

Musicians and familiar faces attend charity carol concert at St Paul’s Cathedral

Last night JDRF teamed up with the Royal Osteoporosis Society to host a charity carol concert at St Paul’s Cathedral. The event featured a lineup of familiar faces, including The Rt. Hon Theresa May MP and Derrick Evans MBE.

Read more
Hybrid closed loop technology
Type 1 technology
19 December 2023

NICE Approves hybrid closed loop for the majority of people living with type 1 diabetes in England and Wales

In an historic advancement in the treatment of type 1 diabetes, the National Institute for Health and Care Excellence (NICE) today approves hybrid closed loop for the majority of people living with type 1 diabetes in England and Wales.

Read more
ELSA testing kits to screen for type 1 diabetes in children
Research
12 December 2023

£20 million type 1 diabetes screening project co-funded by JDRF launches in Europe

EDENT1FI aims to develop a population screening programme for type 1, revolutionising how the condition is diagnosed and managed.